1. Fernandes, Marianne Rodrigues, Rodrigues, Juliana Carla Gomes, Dobbin, Elizabeth Ayres Fragoso, de Assumpção, Paulo Pimentel, Dos Santos, Ney Pereira Carneiro. 2021. Influence of FPGS, ABCC4, SLC29A1, and MTHFR genes on the pharmacogenomics of fluoropyrimidines in patients with gastrointestinal cancer from the Brazilian Amazon. In Cancer chemotherapy and pharmacology, 88, 837-844. doi:10.1007/s00280-021-04327-w. https://pubmed.ncbi.nlm.nih.gov/34331561/
2. Gao, Ping-Ting, Cheng, Jian-Wen, Gong, Zi-Jun, Fan, Jia, Yang, Xin-Rong. 2017. Low SLC29A1 expression is associated with poor prognosis in patients with hepatocellular carcinoma. In American journal of cancer research, 7, 2465-2477. doi:. https://pubmed.ncbi.nlm.nih.gov/29312800/
3. Liu, Mingyang, Zhang, Yuqing, Yang, Jingxuan, Houchen, Courtney W, Li, Min. 2019. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells. In Gastroenterology, 158, 679-692.e1. doi:10.1053/j.gastro.2019.10.038. https://pubmed.ncbi.nlm.nih.gov/31711924/
4. Farías, Marcelo, San Martín, Rody, Puebla, Carlos, Casanello, Paola, Sobrevia, Luis. . Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. In Journal of cellular physiology, 208, 451-60. doi:. https://pubmed.ncbi.nlm.nih.gov/16688763/
5. Takahashi, Takuto, Luzum, Jasmine A, Nicol, Melanie R, Jacobson, Pamala A. 2020. Pharmacogenomics of COVID-19 therapies. In NPJ genomic medicine, 5, 35. doi:10.1038/s41525-020-00143-y. https://pubmed.ncbi.nlm.nih.gov/32864162/
6. Milazzo, Laura, Peri, Anna Maria, Mazzali, Cristina, Antinori, Spinello, Falvella, Felicia Stefania. 2015. SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. In The Journal of antimicrobial chemotherapy, 70, 1155-60. doi:10.1093/jac/dku519. https://pubmed.ncbi.nlm.nih.gov/25583751/
智鼠故事 
